Devang Shah

Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3

Chunjian Liu, Prasada Rao Jalagam, Jianxin Feng et al. · Journal of Medicinal Chemistry · 2022 · 29 citations · Full text

Pharmaceutical Science, Glycobiology, Immunology +18

Design, Structure–Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-<i>b</i>]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors

Richard A. Hartz, Vijay T. Ahuja, Prasanna Sivaprakasam et al. · Journal of Medicinal Chemistry · 2023 · 27 citations · Full text

Synthesis, Structure–Activity Relationships, and In Vivo Evaluation of Novel Tetrahydropyran-Based Thiodisaccharide Mimics as Galectin-3 Inhibitors

Li Xu, Richard A. Hartz, Brett R. Beno et al. · Journal of Medicinal Chemistry · 2021 · 25 citations · Full text

Pharmaceutical Science, Potent Galectin-3 Inhibitors, Bioorganic Chemistry +21

Prediction of pH dependent absorption using in vitro, in silico, and in vivo rat models: Early liability assessment during lead optimization

Ajay Saxena, Devang Shah, Shweta Padmanabhan et al. · European Journal of Pharmaceutical Sciences · 2015 · 21 citations

Biochemistry, Medicine, Bioanalysis +11

A Systematic Evaluation of Solubility Enhancing Excipients to Enable the Generation of Permeability Data for Poorly Soluble Compounds in Caco-2 Model

Devang Shah, Sundeep Paruchury, Muralikrishna Matta et al. · Drug Metabolism Letters · 2014 · 20 citations

Solvent Extraction, Engineering, Flux Data +23